miR-942-5p Inhibits Proliferation, Metastasis, and Epithelial-Mesenchymal Transition in Colorectal Cancer by Targeting CCBE1

In conclusion, we confirmed that miR-942-5p exerts oncogenic actions in CRC by targeting CCBE1 and identified miR-942-5p as a potential clinical biomarker for CRC diagnosis and therapy.PMID:33997050 | PMC:PMC8102100 | DOI:10.1155/2021/9951405

Source: Biomed Res - May 17, 2021 Category: Research Authors: Lin Zhou Qing Chen Jie Wu Jian Yang Huancai Yin Jingjing Tian Lian Gong DanDan Kong Min Tao Source Type: research